IP Library Granted Patent US 10,336,999
Granted Patent B2
US 10,336,999 · App. 15/167,224 · Granted Jul 2, 2019

Compositions and methods for activating silent gene clusters

Inventors: Oliver Liu (San Francisco, CA); Jeffrey Hoon Kim (Berkeley, CA)
Assignee: Zymergen Inc.
C12N15/1072C12N7/00C12N15/63C12N15/76C12N2795/10042
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,336,999
App. No.
15/167,224
Granted
Jul 2, 2019
Kind
B2
Abstract

The disclosure provides compositions and methods for producing natural products in microorganisms that are otherwise unexpressed, poorly expressed or poorly transcribed. In particular aspects, the disclosure provides compositions and methods for activating a silent gene or gene cluster with a bacteriophage and/or Streptomyces Antibiotic Regulatory Protein (SARP) transcription factor.

Claims (14)

1. A method of activating one or more native genes in each bacterial cell in a population of bacterial cells, the method comprising:

infecting the population of bacterial cells with a plurality of recombinant bacteriophage, wherein

(a) the bacteriophage are selected from a collection of recombinant phage comprising different heterologous nucleotide sequences that encode one or more bacterial transcription factors, and

(b) each bacterial cell expresses the one or more native genes because of the expression of the one or more bacterial transcription factors;

wherein the one or more native genes are transcriptionally silent, poorly expressed, or poorly transcribed in a control bacterial cell that has not been infected with the bacteriophage comprising the different heterologous nucleotide sequences encoding the one or more transcription factors; and wherein the population of bacteriophage-infected bacterial cells express different sets of heterologous transcription factors.

2. The method of claim 1 , wherein the one or more transcription factors are selected from transcription factor families consisting of LysR, TetR/AcrR, GntR, AraC, CRO/CI/Xre, OmpR, LuxR/NarL, MarR, LacI, ArsR, Fis, MerR, AsnC/Lrp, DeoR, Crp/Fnr, Fur, PadR, RpiR, Rrf2, DnaA, BolA/YrbA, ROK/NagC/XylR, LytTR, SorC, ArgR, DtxR, LexA, TrmB, BirA, PenR/BlaI/MecI, SfsA, Nlp, Archaeal HTH-10, CopG/RepA, PutA, ModE, PaiB, CtsR, AfsR/DnrI/RedD, CodY, TrpR, MtlR, ROS/MUCR, MetJ, GutM, Crl, ComK, FlhD, RtcR, Spo0A, DctR, NifT/FixU, and Streptomyces Antibiotic Regulatory Protein (SARP) transcription factors.

3. The method of claim 2 , wherein the one or more transcription factors are selected from Streptomyces Antibiotic Regulatory Protein (SARP) transcription factors.

4. The method of claim 1 , wherein the one or more native genes comprise a gene cluster.

5. The method of claim 1 , wherein the bacteriophage are obtained by transforming a bacteriophage vector into a bacterial host cell.

6. The method of claim 5 further comprising collecting and purifying bacteriophage from the bacterial host cell or medium comprising the bacterial host cell.

7. The method of claim 1 further comprising selecting from the population of bacterial cells a bacterial cell expressing the one or more transcription factors and culturing the bacterial cell.

8. The method of claim 1 , wherein the one or more transcription factors are operably linked to one or more heterologous control sequences.

9. The method of claim 1 , wherein the population of bacterial cells are members of phylum Actinobacteria.

10. The method of claim 1 , wherein the bacteriophage are selected from the group consisting of R4, ΦC31, ΦC62, ΦBT1, SV1, and ΦC43.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jul 1, 2022
From: PERCEPTIVE CREDIT HOLDINGS II, LP, AS ADMINISTRATIVE AGENT
To: ZYMERGEN INC.
Reel/Frame 060421/0533 →
PATENT SECURITY AGREEMENT Recorded Dec 26, 2019
From: ZYMERGEN INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 051425/0485 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2018
From: RADIANT GENOMICS, INC.
To: ZYMERGEN INC.
Reel/Frame 045091/0843 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2016
From: LIU, OLIVER; KIM, JEFFREY HOON
To: RADIANT GENOMICS, INC.
Reel/Frame 039157/0822 →
Continuity (2)
Provisional Application 62168631 · May 29, 2015
Related Publication 20160348097A1 · Dec 1, 2016